Selective progesterone receptor modulators in early stage breast cancer: a randomized, placebo-controlled Phase II window of opportunity trial using telapristone acetate.
Lee, Oukseub, Sullivan, Megan E, Xu, Yanfei, Rodgers, Chiara, Muzzio, Miguel, Helenowski, Irene, Shidfar, Ali, Zeng, Zexian, Singhal, Hari, Jovanovic, Borko, Hansen, Nora, Bethke, Kevin P, Gann, PeterJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-19-0443
Date:
September, 2019
File:
PDF, 2.34 MB
2019